142 results
Page 7 of 8
6-K
EX-99.1
vboq04o60 lzem6
17 Jun 14
Teva Reaches Settlements In Nuvigil® Patent Case
12:00am
6-K
EX-99.1
tt8macf6xmbyydnr428
12 Jun 14
Teva Announces U.s. Court of Appeals Upholds Ruling Confirming Invalidity of Baraclude® Patent
12:00am
6-K
EX-99.1
tpgu ft3t3
9 Jun 14
FDA Approves Expanded Label for AZILECT® for Treatment Across All Stages of Parkinson’s Disease
12:00am
6-K
EX-99.1
4oc8b9 t041r84ilr
3 Jun 14
Live Filing
12:00am
6-K
EX-99.1
k3z6gw4qnbv
2 Jun 14
Appoints Sigurdur Olafsson As President and Ceo of Newly Established Global Generic Medicines Group
12:00am
6-K
EX-99.1
w6kqap 13j5zz
30 May 14
Teva Receives Favorable Court Decision Regarding Generic Celebrex ® Capsules; Teva should receive sole exclusivity for generic Celebrex ® Capsules
12:00am
6-K
EX-99.1
nfetpc pie7
27 May 14
Teva Announces Favorable European Patent Office Ruling In COPAXONE® Patent Proceeding
12:00am
6-K
EX-99.1
gmn9 ddua6t4h
23 May 14
Teva Received FDA Approval for QVAR® (beclomethasone dipropionate HFA) with Dose Counter
12:00am
6-K
EX-99.1
06nxzwif p5kzu3ya
29 Apr 14
Teva Receives European Marketing Authorization for DuoResp Spiromax® for the Treatment of Asthma and COPD
12:00am
6-K
EX-99.1
fpkmmyx c3t
28 Apr 14
Teva and Takeda Agree to Commercialize Rasagiline for Parkinson’s Disease Treatment In Japan
12:00am
6-K
EX-99.1
pcmvxed p6a6j6e
28 Apr 14
Live Filing
12:00am
6-K
EX-99.1
thbmqy9i o1
24 Apr 14
Pride-hd Study Enrolling Patients Globally to Further Evaluate Pridopidine for the Symptomatic Treatment of Huntington’s Disease
12:00am
6-K
EX-99.1
gx02s3n 00a
21 Apr 14
Live Filing
12:00am
6-K
EX-99.1
50v3fx4r
15 Apr 14
Teva Announces Launch of Generic Lunesta® Tablets In the United States
12:00am
6-K
EX-99.1
mvet57551rh1bq00
8 Apr 14
Teva Announces First Approval and Launch of Generic Lovaza®capsules In the United States
12:00am
6-K
EX-99.1
bso1k7lbdf fb2sbj
31 Mar 14
Teva Announces U.s. Supreme Court Will Hear Its Appeal on Copaxone® Patent
12:00am
6-K
EX-99.1
px4e6a75wxyu
13 Mar 14
Live Filing
12:00am
6-K
EX-99.1
h902l48fcawb7vqt1ay
7 Mar 14
Teva Announces Launch of Generic Xeloda® Tablets 150 MG and 500 MG In the United States
12:00am
6-K
EX-99.1
j05d65d
3 Mar 14
The first and only orally inhaled medicine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults
12:00am
6-K
EX-99.1
vi8vdqdjy
21 Feb 14
Teva Completes Tender Offer for NuPathe Inc. Shares
12:00am